Figure 5a

Figure 5a

Soquelitinib Treatment Leads to Increase in Persistent Tregs (CD4+, Foxp3+, CD25Hi ) measured by flow cytometry.

Format

JPEG

Quelle:

Corvus Pharmaceuticals, Inc.

Downloads